Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement - PubMed (original) (raw)
. 1989 Jun 22;339(6226):620-2.
doi: 10.1038/339620a0.
Affiliations
- PMID: 2733792
- DOI: 10.1038/339620a0
Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement
N J Scolding et al. Nature. 1989.
Abstract
Oligodendrocytes synthesize myelin in the central nervous system and maintain it in lamellar sheaths around axons. Techniques for studying oligodendrocyte development in vitro can be used, indirectly, to investigate the myelin injury that occurs in human and experimental demyelinating disease. Cell-mediated immune mechanisms are necessary but not sufficient to induce myelin damage in vivo; more recently complement has also been implicated in the pathogenesis both of multiple sclerosis and experimental allergic encephalomyelitis. Previously we have demonstrated that antibody-independent complement activation occurs in vitro at the oligodendrocyte surface. Here we show that the ensuing oligodendrocyte injury is reversible, and that recovery involves the release of membrane-attack complex-enriched vesicles from the surface of viable cells. The demonstration of morphologically and immunochemically identical vesicles in the cerebrospinal fluid of patients with multiple sclerosis suggests that reversible complement-mediated injury contributes to myelin damage in vivo.
Similar articles
- Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
Rus H, Cudrici C, Niculescu F, Shin ML. Rus H, et al. J Neuroimmunol. 2006 Nov;180(1-2):9-16. doi: 10.1016/j.jneuroim.2006.07.009. Epub 2006 Aug 14. J Neuroimmunol. 2006. PMID: 16905199 Review. - Anti-heat shock protein 90beta antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis.
Cid C, Alvarez-Cermeño JC, Salinas M, Alcázar A. Cid C, et al. J Neurochem. 2005 Oct;95(2):349-60. doi: 10.1111/j.1471-4159.2005.03371.x. Epub 2005 Aug 31. J Neurochem. 2005. PMID: 16135098 - Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system.
Zajicek J, Wing M, Skepper J, Compston A. Zajicek J, et al. Lab Invest. 1995 Jul;73(1):128-38. Lab Invest. 1995. PMID: 7541492 - The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis.
Bartlett PF, Mackay IR. Bartlett PF, et al. J Clin Lab Immunol. 1983 May;11(1):1-7. J Clin Lab Immunol. 1983. PMID: 6348293 Review. - Reversible injury of cultured rat oligodendrocytes by complement.
Scolding NJ, Houston WA, Morgan BP, Campbell AK, Compston DA. Scolding NJ, et al. Immunology. 1989 Aug;67(4):441-6. Immunology. 1989. PMID: 2767708 Free PMC article.
Cited by
- Platelet-derived microparticles and their cargos: The past, present and future.
Guo J, Cui B, Zheng J, Yu C, Zheng X, Yi L, Zhang S, Wang K. Guo J, et al. Asian J Pharm Sci. 2024 Apr;19(2):100907. doi: 10.1016/j.ajps.2024.100907. Epub 2024 Mar 21. Asian J Pharm Sci. 2024. PMID: 38623487 Free PMC article. Review. - Interactions Between Extracellular Vesicles and Autophagy in Neuroimmune Disorders.
Ai X, Yu H, Cai Y, Guan Y. Ai X, et al. Neurosci Bull. 2024 Jul;40(7):992-1006. doi: 10.1007/s12264-024-01183-5. Epub 2024 Feb 29. Neurosci Bull. 2024. PMID: 38421513 Review. - Evoked Weibel-Palade Body Exocytosis Modifies the Endothelial Cell Surface by Releasing a Substrate-Selective Phosphodiesterase.
Naß J, Terglane J, Zeuschner D, Gerke V. Naß J, et al. Adv Sci (Weinh). 2024 Apr;11(16):e2306624. doi: 10.1002/advs.202306624. Epub 2024 Feb 15. Adv Sci (Weinh). 2024. PMID: 38359017 Free PMC article. - Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders.
Burgelman M, Dujardin P, Vandendriessche C, Vandenbroucke RE. Burgelman M, et al. Front Immunol. 2023 Jan 20;13:1055050. doi: 10.3389/fimmu.2022.1055050. eCollection 2022. Front Immunol. 2023. PMID: 36741417 Free PMC article. Review. - Extracellular Vesicles in Chronic Demyelinating Diseases: Prospects in Treatment and Diagnosis of Autoimmune Neurological Disorders.
Ovchinnikova LA, Zalevsky AO, Lomakin YA. Ovchinnikova LA, et al. Life (Basel). 2022 Nov 21;12(11):1943. doi: 10.3390/life12111943. Life (Basel). 2022. PMID: 36431078 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources